keyword
MENU ▼
Read by QxMD icon Read
search

Electro Convulsive Therapy

keyword
https://www.readbyqxmd.com/read/30504059/electro-convulsive-therapy-modification-of-its-effect-on-the-autonomic-nervous-system-using-anti-cholinergic-drugs
#1
Søren T Just Christensen, Jonathan Myrup Staalsø, Anders Jørgensen, Pia Weikop, Niels Vidiendal Olsen, Martin Balslev Jørgensen
The antidepressant efficacy of electroconvulsive therapy (ECT) is correlated to the quality of the seizure as measured by EEG but has also been linked to the magnitude of changes in hemodynamic variables. Muscarinic receptor antagonists are frequently used in the treatment, and are known to affect the hemodynamic response. We hypothesized that atropine and glycopyrrolate alter the hemodynamic and autonomic hormonal response to ECT. In a randomized, cross-over study design 23 patients received either atropine, glycopyrrolate or placebo before ECT...
November 23, 2018: Psychiatry Research
https://www.readbyqxmd.com/read/30230424/the-neurostructure-of-morality-and-the-hubris-of-memory-manipulation
#2
Peter A DePergola
Neurotechnologies that promise to dampen (via pharmacologicals), disassociate (via electro-convulsive therapy), erase (via deep brain stimulation), and replace (via false memory creation) unsavory episodic memories are no longer the subject of science fiction. They have already arrived, and their funding suggests that they will not disappear anytime soon. In light of their emergence, this essay examines the neurostructure of normative morality to clarify that memory manipulation, which promises to take away that which is bad in human experience, also removes that which enables human beings to be good...
September 19, 2018: New Bioethics: a Multidisciplinary Journal of Biotechnology and the Body
https://www.readbyqxmd.com/read/30122262/india-s-mental-healthcare-act-2017-content-context-controversy
#3
Richard M Duffy, Brendan D Kelly
India's new mental health legislation, the Mental Healthcare Act, 2017, was commenced on 29 May 2018 and seeks explicitly to comply with the United Nations Convention on the Rights of Persons with Disabilities. It grants a legally binding right to mental healthcare to over 1.3 billion people, one sixth of the planet's population. Key measures include (a) new definitions of 'mental illness' and 'mental health establishment'; (b) revised consideration of 'capacity' in relation to mental healthcare (c) 'advance directives' to permit persons with mental illness to direct future care; (d) 'nominated representatives', who need not be family members; (e) the right to mental healthcare and broad social rights for the mentally ill; (f) establishment of governmental authorities to oversee services; (g) Mental Health Review Boards to review admissions and other matters; (h) revised procedures for 'independent admission' (voluntary admission), 'supported admission' (admission and treatment without patient consent), and 'admission of minor'; (i) revised rules governing treatment, restraint and research; and (j) de facto decriminalization of suicide...
August 16, 2018: International Journal of Law and Psychiatry
https://www.readbyqxmd.com/read/29847351/differences-in-speed-of-response-of-depressive-symptom-dimensions-in-older-persons-during-electroconvulsive-therapy
#4
Eveline M Veltman, Sophie van Hulten, Jos Twisk, Annemiek Dols, Eric van Exel, Max L Stek, Pascal Sienaert, Filip Bouckaert, Roos C van der Mast, Didi Rhebergen
INTRODUCTION: Electroconvulsive therapy (ECT) is an important and effective treatment for depression. However, research on course trajectories of depressive symptoms during ECT is limited. Insight into putative differences in speed of response of depressive symptom dimensions may enable clinicians to optimally inform patients and their relatives. Therefore, we aim to examine course trajectories of depressive symptom dimensions in depressed older persons during ECT. METHODS: Data were derived from the Mood Disorders in Elderly treated with Electro Convulsive Therapy study, including 110 persons, aged 55 years or more, with a current diagnosis of major depressive disorder and referred for ECT...
May 29, 2018: Journal of ECT
https://www.readbyqxmd.com/read/29442207/i-m-shocked-informed-consent-in-ect-and-the-phenomenological-self
#5
Patrick Seniuk
This paper argues that phenomenological insights regarding selfhood are relevant to the informed consent process in the treatment of depression using electro-convulsive therapy (ECT). One of the most significant side-effects associated with ECT is retrograde amnesia. Unfortunately, the current informed consent model does not adequately appreciate the full extent in which memory loss disturbs lived-experience. Through the philosophy of Merleau-Ponty, it is possible to appreciate the way in which memory loss affects a person's self-experience, with emphasis given to one's pre-reflective and embodied, relationship with things in the world...
February 13, 2018: Life Sciences, Society and Policy
https://www.readbyqxmd.com/read/29149755/a-randomized-clinical-trial-of-adjunctive-ketamine-anesthesia-in-electro-convulsive-therapy-for-depression
#6
RANDOMIZED CONTROLLED TRIAL
Minling Zhang, Robert Rosenheck, Xiaoming Lin, Qirong Li, Yanling Zhou, Yunshan Xiao, Xiong Huang, Ni Fan, Hongbo He
BACKGROUND: Electroconvulsive therapy (ECT) is a rapid acting and effective treatment for both major depressive disorder (MDD) and bipolar disorder (BP). Both propofol and ketamine are commonly used anesthetic agents but recent clinical studies suggest that ketamine has rapid-acting antidepressant properties, itself, at sub-anesthetic doses. METHODS: A total of 77 inpatients (41 MDD and 36 BP) were randomly assigned to receive ECT with propofol (1mg/kg) anesthesia or with ketamine (0...
February 2018: Journal of Affective Disorders
https://www.readbyqxmd.com/read/28908725/personal-viewpoint-the-experience-of-electro-convulsive-therapy
#7
(no author information available yet)
No abstract text is available yet for this article.
October 1965: Mental Health
https://www.readbyqxmd.com/read/28594056/the-effect-of-add-on-memantine-on-positive-negative-and-depressive-symptoms-of-schizophrenia-a-doubleblind-randomized-controlled-trial
#8
RANDOMIZED CONTROLLED TRIAL
Victoria Omranifard, Fatemeh Rajabi, Maryam Mohammadian-Sichani, Mohammad Reza Maracy
treatment of schizophrenia, they don’t adequately address residual positive, negative and depressive symptoms. The aim of the present study is to assess the effect of adjunctive memantine treatment on positive, negative and depressive symptoms of schizophrenia. METHODS: This randomized, placebo-controlled study was conducted in Noor Hospital, Isfahan, Iran, 2013-2014; 32 patients in maintenance treatment were included in each group, using block sampling; inclusion criteria were age 18- 65 years, normal intellectual ability, being diagnosed with schizophrenia for the past two years, being treated with fixed doses of atypical antipsychotic for at least three months before randomization...
May 2017: Actas Españolas de Psiquiatría
https://www.readbyqxmd.com/read/28218079/venereo-phobia
#9
R K Dutta, J W Sabhaney
A case of venereo-phobia who was treated successfully with drug assisted systemic desensitization and electro convulsive therapy (ECT) is reported. The patient was an old case of non-specific urefttis who developed fixated ideas to his genital organs in the form of worm-crawling sensation over his penis. The neurosis was associated with free-floating anxiety and masked depression.
July 1980: Indian Journal of Dermatology, Venereology and Leprology
https://www.readbyqxmd.com/read/28192737/a-systematic-review-of-yoga-for-major-depressive-disorder
#10
REVIEW
Holger Cramer, Dennis Anheyer, Romy Lauche, Gustav Dobos
BACKGROUND: The purpose of this review was to investigate the efficacy and safety of yoga interventions in treating patients with major depressive disorder. METHODS: MEDLINE, Scopus, and the Cochrane Library were screened through December 2016. Randomized controlled trials (RCTs) comparing yoga to inactive or active comparators in patients with major depressive disorder were eligible. Primary outcomes included remission rates and severity of depression. Anxiety and adverse events were secondary outcomes...
April 15, 2017: Journal of Affective Disorders
https://www.readbyqxmd.com/read/27822276/demographic-and-diagnostic-features-of-3147-inpatients-with-mood-disorders-in-iran
#11
Atefeh Ghanbari Jolfaei, Pari Ghadamgahi, Masoud Ahmadzad-Asl, Amir Shabani
OBJECTIVES: To assess and compare demographic and diagnostic characteristics of inpatients with mood disorders in Iran. MATERIALS AND METHODS: We collected the demographic, clinical, and treatment characteristics of patients, who were hospitalized during five years from April 2006 to March 2010, in Iran hospital of psychiatry, a residency training center to evaluate the general clinical picture of the disorder. RESULTS: Overall, 95.3% of subjects had a diagnosis of bipolar I disorder (BID), 2...
September 2016: Iranian Journal of Psychiatry and Behavioral Sciences
https://www.readbyqxmd.com/read/27709532/esmolol-bolus-and-infusion-attenuates-increases-in-blood-pressure-and-heart-rate-during-electro-convulsive-therapy
#12
Anthony L Kovac, Hiroshi Goto, Kasumi Arakawa, Manuel P Pardo
To determine whether a standardized dose of esmolol can effectively attenuate the cardiovascular response to electroconvulsive therapy (ECT), 17 ASA physical status I-II patients were studied in a randomized within-patient, crossover design. Each patient received "no esmolol" during one ECT and three to five days later crossed over to the alternative treatment receiving an esmolol 80 mg bolus followed by 24 mg · min-1 infusion two minutes prior to induction of anaesthesia and continued for five minutes after induction...
January 1990: Canadian Journal of Anaesthesia, Journal Canadien D'anesthésie
https://www.readbyqxmd.com/read/27042563/use-of-ect-in-nepal-a-one-year-study-from-the-country-s-largest-psychiatric-facility
#13
Sandip Subedi, Tapas Kumar Aich, Niru Sharma
INTRODUCTION: Electro-Convulsive Therapy (ECT) refers to the electrical stimulation of the brain to produce seizures for therapeutic purpose. Since the development of ECT, it's use has been consistent. Inspite of the common use, data pertaining to the use of ECT in Nepal is lacking. AIM: This study was undertaken with the aim of exploring the clinico-demographic profile of patients treated with ECT in the largest psychiatry facility in the country. MATERIALS AND METHODS: It is a retrospective descriptive study of patients who were treated with ECT after admission in the inpatient psychiatry unit of Universal College of Medical Sciences Teaching Hospital, Bhairahawa, Nepal during a period of one year (August 2012 to July 2013)...
February 2016: Journal of Clinical and Diagnostic Research: JCDR
https://www.readbyqxmd.com/read/27029661/the-effect-of-adjuvant-remifentanil-with-propofol-or-thiopentone-on-seizure-quality-during-electroconvulsive-therapy
#14
R MacPherson, M Marroquin-Harris, V Gálvez, P Tor, C Loo
In order to optimise outcome to Electro Convulsive therapy (ECT), there has been a trend to utilise remifentanil as an adjunct to standard intravenous induction agents. This has allowed a reduction in the dose of anaesthetic agent, and usually an improved response to stimulation. However there have been no previous studies to ascertain whether this improvement is simply as a result of the reduced dose of anaesthetic agent or whether remifentanil itself might possess epileptogenic properties. This retrospective case-controlled study examined ECT outcomes, determined by EEG quality analysis, in patients who received ECT with or without remifentanil, where there was no dose reduction in the anaesthetic agent...
March 2016: Anaesthesia and Intensive Care
https://www.readbyqxmd.com/read/26721476/treatment-escalation-in-patients-not-responding-to-pharmacotherapy-psychotherapy-and-electro-convulsive-therapy-experiences-from-a-novel-regimen-using-intravenous-s-ketamine-as-add-on-therapy-in-treatment-resistant-depression
#15
Bernd Kallmünzer, Bastian Volbers, Anne Karthaus, Ozan Yüksel Tektas, Johannes Kornhuber, Helge H Müller
A lack of response despite maximum therapy is common in patients fulfilling criteria of treatment-resistant depression. Therefore, innovative strategies for treatment escalation are warranted. Here, we report the clinical experiences associated with a novel therapeutic regimen combining electroconvulsive therapy and repeated intravenous S-ketamine treatment in three patients. The combined therapy was feasible and had no serious side effects. All patients responded to the new treatment option. The augmentative effect of sub-anesthetic S-ketamine on ECT is discussed...
May 2016: Journal of Neural Transmission
https://www.readbyqxmd.com/read/26539786/which-anesthetic-agents-for-ambulatory-electro-convulsive-therapy
#16
REVIEW
Ross D MacPherson
PURPOSE OF REVIEW: There have been a considerable number of research articles published in the last 10 years outlining possible advances in the provision of electro-convulsive therapy (ECT) anaesthesia. This has resulted in a range of new drugs having been proposed as useful in the ECT setting. In particular, the use of adjuvant drugs that might improve outcomes to treatment has been investigated. RECENT FINDINGS: There is a high level of interest in ketamine and remifentanil as agents that may alter response in ECT anaesthesia, by reducing cognitive effects, and minimizing the dose of induction agent...
December 2015: Current Opinion in Anaesthesiology
https://www.readbyqxmd.com/read/26529101/brain-derived-neurotrophic-factor-and-antidepressive-effect-of-electroconvulsive-therapy-systematic-review-and-meta-analyses-of-the-preclinical-and-clinical-literature
#17
REVIEW
M Polyakova, M L Schroeter, B M Elzinga, S Holiga, P Schoenknecht, E R de Kloet, M L Molendijk
Emerging data suggest that Electro-Convulsive Treatment (ECT) may reduce depressive symptoms by increasing the expression of Brain-Derived Neurotrophic Factor (BDNF). Yet, conflicting findings have been reported. For this reason we performed a systematic review and meta-analysis of the preclinical and clinical literature on the association between ECT treatment (ECS in animals) and changes in BDNF concentrations and their effect on behavior. In addition, regional brain expression of BDNF in mouse and human brains were compared using Allen Brain Atlas...
2015: PloS One
https://www.readbyqxmd.com/read/26361565/psychosis-and-catatonia-in-fragile-x-case-report-and-literature-review
#18
Tri Indah Winarni, Andrea Schneider, Neera Ghaziuddin, Andreea Seritan, Randi J Hagerman
Fragile X mental retardation 1 (FMR1) premutation associated phenotypes have been explored extensively since the molecular mechanism emerged involving elevated FMR1 messenger ribonucleic acid (mRNA) levels. Lowered fragile X mental retardation protein (FMRP) can also occur which may have an additive effect to the high levels of mRNA leading to neurodevelopmental problems and psychopathology. This paper was aimed to review psychosis and catatonia in premutation carriers, express the role of elevated FMR1 mRNA and lowered FMRP in the phenotype of carriers and present a case of psychosis and catatonia in a carrier...
August 2015: Intractable & Rare Diseases Research
https://www.readbyqxmd.com/read/26151569/treatment-and-prevention-of-depression
#19
Steven D Hollon, Michael E Thase, John C Markowitz
Depression is one of the most common and debilitating psychiatric disorders and is a leading cause of suicide. Most people who become depressed will have multiple episodes, and some depressions are chronic. Persons with bipolar disorder will also have manic or hypomanic episodes. Given the recurrent nature of the disorder, it is important not just to treat the acute episode, but also to protect against its return and the onset of subsequent episodes. Several types of interventions have been shown to be efficacious in treating depression...
November 2002: Psychological Science in the Public Interest: a Journal of the American Psychological Society
https://www.readbyqxmd.com/read/25672720/-anti-nmda-encephalitis-in-psychiatry-malignant-catatonia-atypical-psychosis-and-ect
#20
Takashi Kanbayashi, Ko Tsutsui, Keiko Tanaka, Yuki Omori, Manabu Takaki, Mayu Omokawa, Akane Mori, Hiroaki Kusanagi, Seiji Nishino, Tetsuo Shimizu
The symptoms of malignant (lethal) catatonia has been reported similar to initial symptoms of anti-NMDAR encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed in many psychiatrists. We have experienced several cases with malignant catatonia having anti-NMDAR antibody without clinical signs of encephalitis. Thereafter, we have also found anti-NMDAR antibody positive patients of young females with acute florid psychiatric symptoms without clinical signs of encephalitis. The features of these patients mirror-those of "Atypical psychosis" proposed by Mitsuda in Japan, a notion derived from "Cycloid psychosis" conceptualized by German psychiatrist, Leonhard...
2014: Rinshō Shinkeigaku, Clinical Neurology
keyword
keyword
167596
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"